Dr. Steven Gittler, MD

NPI: 1730176728
Total Payments
$3,503
2022 Payments
$43.64
Companies
25
Transactions
220
Medicare Patients
3,430
Medicare Billing
$344,203

Payment Breakdown by Category

Food & Beverage$3,092 (88.3%)
Gifts$240.00 (6.9%)
Education$170.65 (4.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $3,092 212 88.3%
Gift $240.00 1 6.9%
Education $170.65 7 4.9%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $1,157 101 $0 (2022)
AstraZeneca Pharmaceuticals LP $397.51 22 $0 (2019)
Genentech USA, Inc. $297.10 15 $0 (2019)
Boehringer Ingelheim Pharmaceuticals, Inc. $241.19 11 $0 (2019)
Resmed Corp $240.00 1 $0 (2018)
Gilead Sciences Inc $161.67 11 $0 (2017)
Grifols USA, LLC $152.06 10 $0 (2019)
Sunovion Pharmaceuticals Inc. $136.89 11 $0 (2019)
PFIZER INC. $91.16 5 $0 (2018)
Advanced Respiratory, Inc $81.06 5 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2022 $43.64 3 GlaxoSmithKline, LLC. ($43.64)
2021 $42.19 3 GlaxoSmithKline, LLC. ($42.19)
2019 $973.07 63 GlaxoSmithKline, LLC. ($275.15)
2018 $1,353 83 GlaxoSmithKline, LLC. ($414.43)
2017 $1,092 68 GlaxoSmithKline, LLC. ($381.21)

All Payment Transactions

220 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
03/21/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $13.46 General
Category: RESPIRATORY
02/22/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $15.19 General
Category: RESPIRATORY
01/24/2022 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $14.99 General
Category: RESPIRATORY
07/26/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $12.48 General
Category: RESPIRATORY
04/27/2021 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $11.93 General
Category: RESPIRATORY
03/15/2021 GlaxoSmithKline, LLC. ANORO ELLIPTA (Drug) Food and Beverage In-kind items and services $17.78 General
Category: RESPIRATORY
11/11/2019 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $1.74 General
Category: RESPIRATORY
11/05/2019 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $3.66 General
Category: RESPIRATORY
10/08/2019 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $3.02 General
Category: RESPIRATORY
07/18/2019 Boehringer Ingelheim Pharmaceuticals, Inc. STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT Food and Beverage In-kind items and services $19.63 General
Category: RESPIRATORY
07/17/2019 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug) Food and Beverage In-kind items and services $15.15 General
Category: Cardiology
07/12/2019 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $12.29 General
Category: RESPIRATORY
07/11/2019 ADVANCED RESPIRATORY, INC The Vest System Model 105 Home Care (Device) Food and Beverage In-kind items and services $15.97 General
Category: Airway Clearance Device
07/11/2019 Advanced Respiratory, Inc The Vest System Model 105 Home Care (Device) Food and Beverage In-kind items and services $3.68 General
Category: Airway Clearance Device
07/09/2019 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $13.33 General
07/08/2019 GlaxoSmithKline, LLC. BREO (Drug) Food and Beverage In-kind items and services $18.58 General
Category: RESPIRATORY
07/08/2019 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $8.25 General
Category: RESPIRATORY
07/08/2019 GlaxoSmithKline, LLC. BREO (Drug) Food and Beverage In-kind items and services $1.91 General
Category: RESPIRATORY
07/01/2019 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug) Food and Beverage In-kind items and services $24.07 General
Category: Cardiology
06/29/2019 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $3.13 General
Category: RESPIRATORY
06/28/2019 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $11.23 General
06/27/2019 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $25.30 General
Category: INFLAMMATION AND IMMUNOLOGY
06/18/2019 Novartis Pharmaceuticals Corporation XOLAIR (Biological) Food and Beverage In-kind items and services $16.66 General
Category: RESPIRATORY
06/17/2019 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $9.62 General
Category: RESPIRATORY
06/14/2019 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $22.06 General
Category: RESPIRATORY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 14 843 1,019 $315,573 $79,421
2022 13 842 1,062 $320,425 $81,251
2021 13 810 1,026 $312,844 $83,376
2020 15 935 1,229 $409,440 $100,155
Total Patients
3,430
Total Services
4,336
Medicare Billing
$344,203
Procedure Codes
56

All Medicare Procedures & Services

56 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 156 187 $63,580 $17,245 27.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 188 258 $59,340 $15,887 26.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 71 110 $36,410 $10,687 29.4%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 62 62 $41,106 $9,901 24.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 55 58 $37,816 $8,093 21.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 68 96 $22,080 $6,151 27.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 35 35 $18,725 $4,376 23.4%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 15 16 $7,152 $1,671 23.4%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2023 38 38 $7,600 $1,146 15.1%
94729 Test to examine how well the lungs exchange gases Office 2023 24 24 $4,560 $1,046 22.9%
71046 X-ray of chest, 2 views Office 2023 35 36 $3,600 $844.44 23.5%
94010 Test to measure expiratory airflow and volume Office 2023 38 41 $4,797 $823.46 17.2%
94727 Test to determine lung volumes using gas dilution or washout Office 2023 23 23 $3,220 $803.85 25.0%
95806 Sleep study including heart rate, breathing, airflow, and effort Office 2023 18 18 $5,094 $632.34 12.4%
94010 Test to measure expiratory airflow and volume Facility 2023 17 17 $493.00 $112.20 22.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 161 204 $69,360 $20,265 29.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 211 270 $62,100 $16,791 27.0%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 65 114 $37,734 $9,426 25.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 56 57 $37,164 $8,426 22.7%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 65 118 $27,140 $6,821 25.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 46 46 $24,610 $5,877 23.9%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 37 37 $24,531 $5,859 23.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 18 19 $8,493 $1,900 22.4%
94729 Test to examine how well the lungs exchange gases Office 2022 32 35 $6,634 $1,547 23.3%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2022 39 41 $8,200 $1,246 15.2%

About Dr. Steven Gittler, MD

Dr. Steven Gittler, MD is a Pulmonary Disease healthcare provider based in Hollywood, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730176728.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Gittler, MD has received a total of $3,503 in payments from pharmaceutical and medical device companies, with $43.64 received in 2022. These payments were reported across 220 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,092).

As a Medicare-enrolled provider, Gittler has provided services to 3,430 Medicare beneficiaries, totaling 4,336 services with total Medicare billing of $344,203. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.

Practice Information

  • Specialty Pulmonary Disease
  • Location Hollywood, FL
  • Active Since 10/04/2005
  • Last Updated 03/15/2021
  • Taxonomy Code 207RP1001X
  • Entity Type Individual
  • NPI Number 1730176728

Products in Payments

  • ANORO (Drug) $450.27
  • TRELEGY ELLIPTA (Drug) $288.07
  • AirSense (Device) $240.00
  • BREO (Drug) $228.87
  • Xolair (Biological) $173.55
  • SYMBICORT (Drug) $167.46
  • NUCALA (Biological) $163.68
  • Esbriet (Biological) $123.55
  • Prolastin-C (Biological) $111.72
  • OFEV (Drug) $111.32
  • FASENRA (Drug) $93.01
  • BEVESPI AEROSPHERE (Drug) $91.62
  • The Vest System Model 105 Home Care (Device) $81.06
  • DUPIXENT (Biological) $75.59
  • XOLAIR (Biological) $72.66
  • CHANTIX (Drug) $71.54
  • STIOLTO RESPIMAT (Drug) $65.78
  • UPTRAVI (Drug) $60.86
  • Adempas (Drug) $58.43
  • UTIBRON (Drug) $53.02

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pulmonary Disease Doctors in Hollywood